During the past decade, The Chattanooga Heart Institute conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 5 clinical trials were completed, i.e. on average, 250% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "The Chattanooga Heart Institute" #1 sponsor was "Abbott Medical Devices" with 1 trials, followed by "Alexion" with 1 trials sponsored, "Baim Institute for Clinical Research" with 1 trials sponsored, "Biosensors Europe SA" with 1 trials sponsored and "Boehringer Ingelheim" with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "The Chattanooga Heart Institute" #1 collaborator was "Medtronic" with 2 trials as a collaborator, "Abbott" with 1 trials as a collaborator, "Boston Scientific Corporation" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator and "Cordis Corporation" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "The Chattanooga Heart Institute" are "Acute Coronary Syndrome" (2 trials), "Atrial Fibrillation" (2 trials), "Coronary Artery Disease" (2 trials), "Heart Failure" (2 trials) and "Acute Myocardial Infarction" (1 trials). Many other conditions were trialed in "The Chattanooga Heart Institute" in a lesser frequency.

Most popular intervention types in "The Chattanooga Heart Institute" are "Drug" (8 trials) and "Device" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "AV Node ablation and device implant" (1 trials), "Antiplatelet Drug" (1 trials), "Apixaban" (1 trials) and "Aspirin" (1 trials). Other intervention names were less common.

The vast majority of trials in "The Chattanooga Heart Institute" are 10 trials for "All" genders.

Currently, there are NaN active trials in "The Chattanooga Heart Institute". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in The Chattanooga Heart Institute, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in The Chattanooga Heart Institute, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".